OSTX

OS Therapies Inc

Phase 1 AI-extracted

OST-504

castration resistant prostate cancer

6d ago ~ Jun 30, 2026

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

Approval AI-extracted

OST-HER2

osteosarcoma

T-minus 86 days ~ Sep 30, 2026

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

PDUFA AI-extracted

OST-HER2

osteosarcoma

T-minus 86 days ~ Sep 30, 2026

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

Phase 3 AI-extracted

OST-HER2

osteosarcoma

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

Phase 2 AI-extracted

OST-HER2

osteosarcoma

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

AdCom AI-extracted

OST-HER2

osteosarcoma

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

Phase 1 AI-extracted

OST-HER2

prevention or delay of recurrence in fully resected, pulmonary metastatic osteosarcoma

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

CRL AI-extracted

OST-HER2

prevention or delay of recurrence in fully resected, pulmonary metastatic osteosarcoma

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →

OSTX

OS Therapies Inc

Phase 2 AI-extracted

OST-503

non-small cell lung cancer

Date TBD Date TBD

SEC 8-K verified 11h ago

Countdown card →